Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label prophylaxis of organ rejection. Show all posts
Showing posts with label prophylaxis of organ rejection. Show all posts
Tuesday, September 24, 2024

FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection

›
Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the need...
Friday, October 2, 2015

Envarsus XR granted FDA orphan drug designation for prophylaxis of organ rejection in kidney transplant patients

›
Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that Envarsus ® XR was     granted Orphan Drug status by the U.S. F...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.